Detalhe da pesquisa
1.
Challenges and opportunities in implementing the FDA default parametric tolerance interval two one-sided test for delivered dose uniformity of orally inhaled products.
AAPS PharmSciTech
; 12(4): 1144-56, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21901649
2.
A two one-sided parametric tolerance interval test for control of delivered dose uniformity--part 3--investigation of robustness to deviations from normality.
AAPS PharmSciTech
; 10(3): 829-40, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19551517
3.
A two one-sided parametric tolerance interval test for control of delivered dose uniformity. Part 1--characterization of FDA proposed test.
AAPS PharmSciTech
; 10(3): 820-8, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19551518
4.
A two one-sided parametric tolerance interval test for control of delivered dose uniformity--part 2--effect of changing parameters.
AAPS PharmSciTech
; 10(3): 841-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19551519
5.
Inhalation devices and patient interface: human factors.
AAPS J
; 17(2): 457-61, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25589457
6.
A respiratory product for children--development and submission experiences.
Int J Pharm
; 469(2): 263-4, 2014 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24560645